Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucinex 1200mg for Mucociliary Clearance in Acute Respiratory Infection
NCT01114581Phase 2Completed
- Sponsor
- Reckitt
- Start
- Apr 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetaminophen in Acute Respiratory Infection (ARI), sponsored by Reckitt. Primary endpoint: Percent of Inhaled Radioactive Tracer Particles Cleared From Lungs at 3 hours. Started Apr 2010; status: completed.
02
Drugs
acetaminophen
03
Conditions
Acute Respiratory Infection (ARI)
Beyond the preview
Go deeper on NCT01114581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01114581.